Highlights
- 6 customers signed to VolparaEnterpriseTM by Dec 31st, including Stanford University Hospital (California, USA), in line with internal forecasts
- Contract sizes range from US$12,000 to US$94,800 per year
- Largest total contract value to date signed US$474,000 (5-year deal)
- Shift to focus on annual subscription sales model for all customers is progressing according to plan.
Wellington, NZ, 31 January 2017: Volpara Health Technologies (“Volpara”; ASX:VHT), a digital health company focused on early detection of breast cancer by improving quality of screening, has today released its Appendix 4C Quarterly Cash Flow report for the quarter ending 31st December 2016 (Q3).
For further information please download PDF attached:
Download this document
